Page 1

+ SURGERY PARTNERS SURGERY PARTNERS , INC . ANNOUNCES SECOND QUARTER 2021 RESULTS Exhibit 99.1 BRENTWOOD , Tenn . , August 4 , 2021 ( GLOBE NEWSWIRE ) - Surgery Partners , Inc. ( NASDAQ : SGRY ) ( " Surgery Partners " or the " Company " ) , a leading provider of surgical services , today announced results for the second quarter ended June 30 , 2021 . Revenues increased approximately 45 % from the prior year period to $ 543.3 million ° Days adjusted same - facility revenues increased 45 % from the prior year period о Days adjusted same - facility case volume increased 68 % from the prior year period Net loss attributable to common stockholders was $ 26.9 million о Adjusted EBITDA increased to $ 75.9 million , growth of approximately 30 % over the prior year period ° Adjusted EBITDA excluding the benefit from CARES Act grant recognition increased to $ 73.0 million , growth of approximately 134 % over the prior year period ° 2021 Full year Adjusted EBITDA guidance increased to at least $ 325 million Wayne DeVeydt , Executive Chairman of the Board of Surgery Partners , stated , “ Our second quarter results continue the strong performance from our first quarter of 2021 as our business continues to rebound from the pandemic . During this quarter , we saw recovery in all service lines and resiliency in the higher acuity cases , as more patients , physicians and payors experience the value of our short - stay facilities . We are emerging from the pandemic in a stronger position operationally and financially to capture the growing share of surgical cases migrating to lower - cost , high clinical quality facilities that our partnerships provide . This momentum gives us confidence to increase our projected outlook for the remainder of the year . " Eric Evans , Chief Executive Officer , stated , " The investments we have made and continue to make have positioned us well to support the rapid shift of care to higher value settings . When combined with our relentless focus on recruiting the best doctors , we are seeing a sustainable shift in our case mix . Our results this quarter demonstrate that strength , with same - facility revenue growth of 45 % compared to the same quarter last year and same facility volumes that achieved nearly 104 % of the same quarter in 2019. " " We continue to focus on shifting higher acuity procedures into our purpose - built , lower cost settings . In the second quarter of 2021 , total joint volume in our ASCs grew by 144 % , with approximately one - third of our volume inside the quarter coming from Medicare procedures . We are excited to continue to grow this service line into 2022 and beyond . " Tom Cowhey , Chief Financial Officer , commented , " Given the strength of the Company's performance and its liquidity position , we continue to prudently evaluate investment opportunities that align with our strengths and the dynamic market landscape . We are pleased to have deployed over $ 100 million of capital year to date August , and we have a robust pipeline with over $ 200 million of acquisitions under letter of intent . We remain confident in our ability to accretively deploy capital with strategically relevant partners in the second half of 2021. " Second Quarter 2021 Results Revenues for the second quarter of 2021 increased 45.0 % to $ 543.3 million from $ 374.7 million for the second quarter of 2020. Days adjusted Same- facility Revenues for the second quarter of 2021 increased 44.8 % from the same period last year , with a decrease in revenue per case of 14.0 % and an increase in same - facility cases of 68.3 % . For the second quarter of 2021 , the Company's net loss attributable to common stockholders and Adjusted EBITDA was $ 26.9 million and $ 75.9 million , respectively , compared to $ 42.2 million and $ 58.2 million for the same period last year . Adjusted EBITDA benefited from the recognition of $ 2.9 million of CARES Act grants inside the quarter . Excluding CARES Act grants , Adjusted EBITDA would have been $ 73.0 million . Year to Date 2021 Results Revenues year - to - date 2021 increased 29.4 % to $ 1,055.7 million from $ 815.7 million for the 2020 period . Days adjusted Same - facility Revenues for to - date 2021 increased 28.9 % from the same period last year , with a decrease in revenue per year- 1